209 related articles for article (PubMed ID: 10629646)
1. Effects on blood coagulation of adjuvant CNF (cyclophosphamide, novantrone, 5-fluorouracil) chemotherapy in stage II breast cancer patients.
Pectasides D; Tsavdaridis D; Aggouridaki C; Tsavdaridou V; Visvikis A; Tsatalas K; Fountzilas G
Anticancer Res; 1999; 19(4C):3521-6. PubMed ID: 10629646
[TBL] [Abstract][Full Text] [Related]
2. Blood coagulation during adjuvant epirubicin/cyclophosphamide chemotherapy in patients with primary operable breast cancer.
von Tempelhoff GF; Dietrich M; Hommel G; Heilmann L
J Clin Oncol; 1996 Sep; 14(9):2560-8. PubMed ID: 8823336
[TBL] [Abstract][Full Text] [Related]
3. A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.
Bennett JM; Muss HB; Doroshow JH; Wolff S; Krementz ET; Cartwright K; Dukart G; Reisman A; Schoch I
J Clin Oncol; 1988 Oct; 6(10):1611-20. PubMed ID: 3049953
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide, mitoxantrone, fluorouracil versus conventional CMF as adjuvant treatment in node-positive breast cancer patients. A Hellenic Cooperative Oncology Group Study.
Fountzilas G; Polichronis A; Katsohis K; Gennatas K; Toussis D; Skarlos D; Kosmidis P; Vassilaros S; Semoglou C; Giannakakis T; Fahantidis E; Klouvas G; Tsavaris N; Konstantaras C; Makrantonakis P; Kolotas C; Zamboglou N; Tsiliakos S; Hainoglou D; Mylonakis N; Pavlidis N
Oncology; 1996; 53(2):137-46. PubMed ID: 8604240
[TBL] [Abstract][Full Text] [Related]
5. A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancer.
Alonso MC; Tabernero JM; Ojeda B; Llanos M; Solà C; Climent MA; Seguí MA; López JJ
Breast Cancer Res Treat; 1995 Apr; 34(1):15-24. PubMed ID: 7749156
[TBL] [Abstract][Full Text] [Related]
6. CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus cnf (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: a phase III randomized multicenter study.
Ron IG; Wigler N; Borovik R; Brufman G; Rizel S; Shani A; Brenner J; Farbstein H; Dale A; Inbar MJ; Brenner HJ; Chaitchik S; Catane R
Am J Clin Oncol; 2001 Aug; 24(4):323-7. PubMed ID: 11474254
[TBL] [Abstract][Full Text] [Related]
7. A clinical trial of mitoxantrone (novantrone) versus doxorubicin (adriamycin) in combination chemotherapy for metastatic breast cancer.
Büyükünal E; Derman U; Serdengecti S; Berkarda B
Chemioterapia; 1987 Oct; 6(5):377-9. PubMed ID: 3322590
[TBL] [Abstract][Full Text] [Related]
8. CMF (cyclophosphamide, methotrexate, 5-fluorouracil) versus CNF (cyclophosphamide, mitoxantrone, 5-fluorouracil) as adjuvant chemotherapy for stage II lymph-node positive breast cancer: results by demographic and clinical subgroups.
Ron IG; Wigler N; Borovik R; Peretz T; Rizel S; Shani A; Brenner J; Farbstein H; Brenner HJ; Chaitchik S; Catane R; Inbar MJ
Am J Clin Oncol; 2002 Oct; 25(5):520-2. PubMed ID: 12393997
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study.
Fountzilas G; Stathopoulos G; Kouvatseas G; Polychronis A; Klouvas G; Samantas E; Zamboglou N; Kyriakou K; Adamou A; Pectasidis D; Ekonomopoulos T; Kalofonos HP; Bafaloukos D; Georgoulias V; Razis E; Koukouras D; Zombolas V; Kosmidis P; Skarlos D; Pavlidis N;
Am J Clin Oncol; 2004 Feb; 27(1):57-67. PubMed ID: 14758135
[TBL] [Abstract][Full Text] [Related]
10. Cardiotoxicity evaluation in patients treated with a mitoxantrone combination as adjuvant chemotherapy for breast cancer.
Fountzilas G; Afthonidis D; Geleris P; Salem N; Kottas G; Halkidis C; Apostolidis P; Beer M; Tourkantonis A
Anticancer Res; 1992; 12(1):231-4. PubMed ID: 1567171
[TBL] [Abstract][Full Text] [Related]
11. Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients.
Mukherjee SD; Swystun LL; Mackman N; Wang JG; Pond G; Levine MN; Liaw PC
Pathophysiol Haemost Thromb; 2010; 37(2-4):88-97. PubMed ID: 21430357
[TBL] [Abstract][Full Text] [Related]
12. CNF combination as adjuvant treatment in breast cancer patients is well tolerated.
Hirvikoski PP; Kumpulainen EJ; Johansson RT
Anticancer Drugs; 1997 Apr; 8(4):376-8. PubMed ID: 9180391
[TBL] [Abstract][Full Text] [Related]
13. Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.
Stewart DJ; Evans WK; Shepherd FA; Wilson KS; Pritchard KI; Trudeau ME; Wilson JJ; Martz K
J Clin Oncol; 1997 May; 15(5):1897-905. PubMed ID: 9164200
[TBL] [Abstract][Full Text] [Related]
14. A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy.
Rella C; Coviello M; Giotta F; Maiello E; Colavito P; Colangelo D; Quaranta M; Colucci G; Schittulli F
Breast Cancer Res Treat; 1996; 40(2):151-9. PubMed ID: 8879681
[TBL] [Abstract][Full Text] [Related]
15. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results.
Rouëssé J; de la Lande B; Bertheault-Cvitkovic F; Serin D; Graïc Y; Combe M; Leduc B; Lucas V; Demange L; Nguyen TD; Castèra D; Krzisch C; Villet R; Mouret-Fourme E; Garbay JR; Noguès C;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1072-80. PubMed ID: 16504757
[TBL] [Abstract][Full Text] [Related]
16. Treatment-related leukemia in breast cancer patients treated with fluorouracil-doxorubicin-cyclophosphamide combination adjuvant chemotherapy: the University of Texas M.D. Anderson Cancer Center experience.
Diamandidou E; Buzdar AU; Smith TL; Frye D; Witjaksono M; Hortobagyi GN
J Clin Oncol; 1996 Oct; 14(10):2722-30. PubMed ID: 8874333
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of adjuvant chemotherapy cyclophosphamide, mitoxantrone, and fluorouracil in women with breast cancer.
Kumpulainen EJ; Hirvikoski PP; Johansson RT
Acta Oncol; 2008; 47(1):120-3. PubMed ID: 18097780
[TBL] [Abstract][Full Text] [Related]
18. [Adjuvant CMF chemotherapy in patients with breast cancer--results on blood coagulation and fibrinolysis].
Oberhoff C; Winkler UH; Tauchert AM; Schindler AE
Zentralbl Gynakol; 1997; 119(5):211-7. PubMed ID: 9281254
[TBL] [Abstract][Full Text] [Related]
19. Phase III trial of concurrent or sequential adjuvant chemoradiotherapy after conservative surgery for early-stage breast cancer: final results of the ARCOSEIN trial.
Toledano A; Azria D; Garaud P; Fourquet A; Serin D; Bosset JF; Miny-Buffet J; Favre A; Le Floch O; Calais G
J Clin Oncol; 2007 Feb; 25(4):405-10. PubMed ID: 17264336
[TBL] [Abstract][Full Text] [Related]
20. Conventional adjuvant chemotherapy versus single-cycle, autograft-supported, high-dose, late-intensification chemotherapy in high-risk breast cancer patients: a randomized trial.
Leonard RC; Lind M; Twelves C; Coleman R; van Belle S; Wilson C; Ledermann J; Kennedy I; Barrett-Lee P; Perren T; Verrill M; Cameron D; Foster E; Yellowlees A; Crown J;
J Natl Cancer Inst; 2004 Jul; 96(14):1076-83. PubMed ID: 15265969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
